ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2010
Prevention of HIV infection among injection drug users in resource-limited settings.
Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 108 citations in OpenAlex.
- Effectiveness of interventions for changing HIV related risk behaviours among key populations in low-income setting: A Meta-Analysis, 2001-2016.Scientific reports · 2020Pooled it
- Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review.AIDS and behavior · 2015Pooled it
- Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.AIDS and behavior · 2013Pooled it
- High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.BMC public health · 2013Pooled it
- Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.Journal of acquired immune deficiency syndromes (1999) · 2018Trial
- Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.Journal of acquired immune deficiency syndromes (1999) · 2015Trial
- The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.Preventive medicine · 2014Trial
- Trial
- "Either way, they will use. And so, probably, would you:" A critical discourse analysis of harm reduction portrayal in United States opinion news media.The International journal on drug policy · 2025Article
- Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.Addiction science & clinical practice · 2022Article
- Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.The International journal on drug policy · 2021Article
- The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study.Canadian journal of public health = Revue canadienne de sante publique · 2019Article
- Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.Drug and alcohol dependence · 2019Article
- Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14Journal of leukocyte biology · 2018Article
- Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.Journal of substance abuse treatment · 2018Article
- HIV/AIDS and the African-American Community 2018: a Decade Call to Action.Journal of racial and ethnic health disparities · 2018Article
- Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.Annual review of public health · 2018Article
- Drug-related stigma and access to care among people who inject drugs in Vietnam.Drug and alcohol review · 2018Article
- Gender Differences in HIV Sexual Risk Behaviors Among Clients of Substance Use Disorder Treatment Programs in the U.S.Archives of sexual behavior · 2017Article
- Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam.Harm reduction journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of approximately 16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub-Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (ie, methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.